Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients.
D000368:Aged; D001835:Body Weight; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy / Q000378:metabolism*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D008762:Methylhistidines / Q000097:blood; D008875:Middle Aged; D009132:Muscles / Q000378:metabolism; D009747:Nutritional Physiological Phenomena; D011506:Proteins / Q000378:metabolism*; D012016:Reference Values; D014750:Vincristine / Q000627:therapeutic use
D008762:Methylhistidines; D011506:Proteins; D014750:Vincristine; D008130:Lomustine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005947:Glucose; C028118:3-methylhistidine